MetaCap

Arbutus Biopharma Statistics

NASDAQ: ABUSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

4.02-0.05 (-1.23%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Arbutus Biopharma by the numbers

Arbutus Biopharma has a market capitalization of $616.2 million based on 153.29M shares outstanding. Its trailing P/E ratio is 3.6. The stock trades 7.6% below its 50-day average and 10.3% below its 200-day average.

Average daily trading volume is 4.98M shares, or about $20.0 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ABUS valuation vs. peer median

ABUS compared with the median of 8 peer companies
MetricABUSPeer medianDifference
Market cap$616.24M$625.81M-2%
Avg. volume4.98M1.25M+297%

Peer median across 8 companies: JANX, OLMA, KURA, SGMT, ANNX, IMMX, NVCT, APMD.

Valuation

Market cap
$616.24M
Price / sales (latest FY)
43.76

Price and trading

Previous close
4.07
Open
4.01
Day range
3.97 – 4.09
52-week range
3.50 – 5.45
52-week change
-6.73%
Beta
—
Volume
2.99M

Dividends and events

Annual dividend
None
Next earnings date
Nov 10, 2026

Additional statistics

Market Cap
616.24M
Pe
3.59
Forward Pe
-24.32
Eps
1.12
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
5.45
Week52 Low
3.50
Avg Volume
4.98M
Shares Outstanding
153.29M
Ma50
4.35
Ma200
4.48
Earnings Date
Nov 10, 2026
Pct From52w High
-26.24%
Pct From52w Low
14.86%

Related